Ezetimibe and Tricuspid valve incompetence - a phase IV clinical study of FDA data

Summary:

Tricuspid valve incompetence is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 60+ old, also take Lasix, and have Upper respiratory tract infection.

The phase IV clinical study analyzes which people have Tricuspid valve incompetence when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Tricuspid valve incompetence?

Tricuspid valve incompetence (inefficient heart valve) is found to be associated with 1,197 drugs and 1,198 conditions by eHealthMe. Check the latest studies of Tricuspid valve incompetence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 54 people (0.18%) have Tricuspid valve incompetence.

Could Ezetimibe cause Tricuspid valve incompetence?

Among these 54 people:

What is the gender of people who have Tricuspid valve incompetence when taking Ezetimibe? *

female: 27.08 %
male: 72.92 %

What is the age of people who have Tricuspid valve incompetence when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

What are other side effects people have besides Tricuspid valve incompetence? *

Mitral Valve Incompetence (inefficient heart valve): 40 people, 74.07%
Diarrhea: 25 people, 46.30%
Fatigue (feeling of tiredness): 24 people, 44.44%
Pericardial Effusion (fluid around the heart): 21 people, 38.89%
Cardiac Failure Congestive: 19 people, 35.19%
Thrombocytopenia (decrease of platelets in blood): 16 people, 29.63%
Pneumonia: 14 people, 25.93%
Right Ventricular Systolic Pressure Increased: 13 people, 24.07%
Fluid Overload (too much fluid in the blood): 13 people, 24.07%
Hypovolaemia (a decreased volume of circulating blood in the body): 13 people, 24.07%

What are the existing conditions these people have? *

Upper Respiratory Tract Infection: 13 people, 24.07%
Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 10 people, 18.52%
Latent Tuberculosis (hidden tuberculosis): 10 people, 18.52%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 9.26%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 9.26%
Weight Increased: 4 people, 7.41%
Cardiac Failure Congestive: 3 people, 5.56%
Aortic Valve Incompetence: 3 people, 5.56%
Haemorrhage (bleeding): 3 people, 5.56%
Breast Cancer Metastatic: 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Tricuspid valve incompetence?

- Check whether Tricuspid valve incompetence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,849 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tricuspid valve incompetence:

Tricuspid valve incompetence (1,197 drugs)

Browse all the conditions that are associated with Tricuspid valve incompetence:

Tricuspid valve incompetence (1,198 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.